1 2 docosahexanoyl sn glycero 3 phosphoserine calcium - Medications

EnBrace® HR is an orally administered prescription prenatal vitamin for therapeutic use formulated for adult patients who are under specific and directr monitoring of a licensed medical practitioner. EnBrace® HR contains a small amount of iron and may be taken concurrently with iron supplementation. ​INGREDIENTS: Control-release, citrated folic acid, DHF+ (B 9 - Provitamin) 1 mg ​1 Vitamin B 12 [cobamamide] 50 mcg ​2 FeGC [ferrous glycine cysteinate] (1.5 mg elemental iron) 13.6 mg ​3 ALSO CONTAINS: Folinic acid (B 9 -vitamer) 2.5 mg ​1 Levomefolic acid (B 9 & B 12 - cofactor) 5.23 mg ​4 1 6 mg DFE folate (vitamin B 9 ) 2 The form most found in mammalian liver - adjusted for stability and pH in the presence of stomach substance, is a cobamamide, or vitamin B 12 3 Pure amino acid, cysteinated iron chelate as AminoFerTM* under exclusive license 4 9 mg DFE l-methylfolate magnesium (molar equivalent) * AminoFerTM (Viva Pharmaceuticals, Canada) U.S. Patent # 7,341,708

PaxLyte is an orally administered prescription vitamin for therapeutic use formulated for patients who are under specific direction and monitoring of homocysteine (HCY) status by a physician. It is specifically formulated for patients with deficiencies in folate and vitamin B 12 , including those with genetic polymorphisms affecting homocysteine metabolism. A recent study + suggested that PaxLyte was effective in lowering homocysteine levels in patients that are positive for MTHFR (methylenetetrahydrofolate reductase polymorphism). + ClinicalTrials.gov identifier: NCT02709668, Correlation of Clinical Response With Homocysteine Reduction During Therapy With Reduced B Vitamins in Patients with MDD Who Are Positive for MTHFR C677T or A1298C Polymorphism.